IN

Intact Therapeutics

YC W19 ↗

San Francisco, US · Founded 2015 · 4 employees · 2 known investors

intacttherapeutics.com ↗

Intact Therapeutics develops next-generation biopharmaceutical therapies for gastrointestinal diseases to address unmet clinical needs. The company is clinical-stage and focused on improving patient outcomes through innovative medicines.

Founders & leadership· Y Combinator alumni (W19)

RP

Ravi PamnaniinFounder/CEO

SS

Sidhartha SinhainFounder

Investors · 2

BR

Brightstone Venture CapitalMinneapolis · $250K – $10M

Y

Y CombinatorSan Francisco · $500K